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stem cells. Perhaps more interestingly, 
BMP-2 expression has recently been found 
to be high in senescent VSMCs. 14 Th is 
suggests that nanocrystal uptake by 
VSMCs may promote premature  ‘ ageing ’ 
of these cells, promoting expression of 
morphogens that drive calcifi cation. Th is 
is consistent with ageing being a major 
risk factor for calcifi cation and suggests 
that only a subset of dysfunctional cells 
that take up Ca / P crystals may be enough 
to cause major eff ects on the surrounding 
tissue. It is now critical that we dissect the 
factors that induce expression of key sub-
sets of osteo / chondrocytic proteins in 
VSMCs and clarify the function of these 
proteins in the context of the vessel wall 
rather than just infer their function from 
studies in bone. 
 In summary, this new study by Sage 
 et al. 2 reopens, in a timely manner, a 
number of areas for debate and critical 
experimental analysis in the field of 
vascular calcifi cation. It supports the notion 
that  ‘ calcium begets calcium ’ by aff ecting 
the phenotype of surrounding cells in its 
earliest stages. It also cautions the field 
regarding how we interpret the expression 
of osteogenic proteins by VSMCs, and a 
more critical analysis of the extent, time 
course, and functionality of these proteins 
in the vasculature is required. Finally, 
it highlights a role for nanocrystals 
themselves in promoting calcification 
and suggests we now need to improve 
our understanding of the molecular 
mechanisms leading to the initial 
deposition of Ca / P in the vessel wall. 
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 Gender aff ects the prevalence and pro-
gression of renal disease in both humans 
and animals. In a variety of renal diseases, 
women have a slower deterioration of kid-
ney function than men. Th is female  ‘ pro-
tection ’ has been shown in membranous 
glomerulopathy, polycystic kidney dis-
ease, chronic renal disease of unknown 
etiology, focal segmental glomeruloscle-
rosis, and probably IgA nephropathy. 1,2 
Whether the gender disparity in renal 
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 disease progression is related to known 
progression factors for renal disease, such 
as proteinuria, is unclear. Th ese fi ndings 
in humans are paralleled in many animal 
models of renal disease, such as aging, 
ablation, hypertension, and polycystic 
kidney disease, in which females either are 
protected from the development of 
glomerulosclerosis or have more modest 
renal disease. 3 Interestingly, in certain 
experimental models of diabetic neph-
ropathy, as well as in hyperlipidemic ani-
mal models, female sex is not protective 
and, in fact, serves as a risk factor for renal 
disease progression. 3 Diabetic renal dis-
ease progression in humans does not 
appear to have a clear sex predilection, 
although recent data suggest that renal 
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disease progression in diabetes may be 
related to the interplay of blood sugar 
control and gender. 3 
 In both humans and laboratory animals, 
the specifi c causes underlying the sex dif-
ferences in renal disease progression are 
unclear but have been speculated to 
involve factors such as innate sex-related 
variability in kidney size, weight, and 
nephron number, gender diff erences in 
systemic and glomerular hemodynamics, 
diff erences in diet, and the direct eff ects of 
estrogens and androgens on renal tissue. 3 
In animals, there has been considerable 
investigation into the direct effects of 
estrogens and androgens on renal disease 
progression. These studies routinely 
reduce or eliminate endogenous sex hor-
mones by ovariectomy or castration and 
then manipulate serum hormone levels by 
exogenous addition of either estradiol or 
testosterone. Evidence points toward 
estradiol as a protective factor in the kid-
ney and testosterone either as a  ‘ bystander ’ 
or as injurious, depending on the model 
studied. 3 Th e mechanism by which estra-
diol is protective has been suggested, in 
some studies, to be via inhibition of trans-
forming growth factor-   (TGF-   )-
induced collagen synthesis 4 ( Figure 1 ) .
 Analogously to studies in vascular 
 tissue, studies of cultured male renal 
mesangial cells have shown that estradiol 
suppresses collagen synthesis and 
 stimulates metalloproteinase activity via 
activation of estrogen receptors and, in 
the case of type I collagen, via nongenomic 
activation of the mitogen-activated 
 protein kinase (MAPK) system. 5,6 
 Both   - and   -estrogen receptors (ER  
and ER  ) have been detected in the kid-
ney, 7 and specifi cally in mesangial cells. 6 
Th ese receptors have 47 % overall homol-
ogy and even higher similarity in their 
DNA-binding domains. Both receptors 
show high affi  nity for estradiol and are 
oft en found in the same tissue mediating 
diff erent eff ects of estradiol. For example, 
ER  may inhibit ER  -mediated gene 
expression, and ER  seems to infl uence 
the compensatory renal response to par-
tial nephrectomy. 7 Although, in mice with 
manipulated estrogen receptors, the lack 
of ER  results in excessive production of 
estrogen, testosterone, and luteinizing 
hormone, ER  -defi cient mice have nor-
mal gonadal hormone production. Th e 
ratio of, and specifi c interplay between, 
ER  and ER  appear to be cell type 
dependent. For example, in smooth mus-
cle cells, loss of ER  eliminates inhibition 
of MAPK activation, whereas in cultured 
endothelial cells, this is not found. 8 In 
addition, a recent study suggests that male 
and female kidneys may have diff erent 
quantities of androgen and estrogen 
receptors and that the change in sex hor-
mone receptor quantity in response 
to injury, such as nephrectomy, may be 
gender dependent. 8 
 Doublier and co-workers 9 (this issue) 
now evaluate the eff ects of testosterone 
and 17  -estradiol on the renal podocytes 
of   -estrogen receptor knockout (  ERKO) 
mice, transgenic for the ER  deletion, 
 in vivo , and on cultured podocytes 
obtained from the C57B / 6 mice, which 
have intact ER  , ER  , and androgen 
receptors. In contrast to the wild-type 
mouse, which is resistant to the develop-
ment of glomerulosclerosis, the   ERKO 
animals are interesting in that they exhibit 
excessive ovarian testosterone production 
and develop glomerulosclerosis at an early 
age. Ovariectomy in these animals reduces 
serum testosterone levels and inhibits the 
development of glomerulosclerosis. 10 
Doublier  et al . 9 report that   ERKO mice 
develop podocyte damage as evidenced by 
glomerular staining of desmin and 
nephrin and the extent of apoptosis. Th is 
damage is mitigated by ovariectomy, 
suggesting that testosterone mediates 
podocyte damage in this model. In con-
trast, ovariectomy of the wild-type mouse 
does not aff ect staining for desmin and 
nephrin, apoptosis, or podocyte number. 
If supplemental testosterone is given to 
these wild-type, ovariectomized mice, sig-
nifi cant podocyte injury is detected. In a 
variety of renal cell types and renal injury 
models, estradiol prevents apoptosis. In a 
similar manner, in this study by Doublier 
 et al . 9 estradiol inhibits the development 
of apoptosis induced by TGF-  , tumor 
necrosis factor-  , and testosterone in cul-
tured podocytes from wild-type C57B / 6 
mice. In contrast to studies elucidating 
estradiol ’ s inhibition of testosterone-
induced apoptosis through its interaction 
with TGF-  , 4 in this model, inhibition of 
testosterone-induced apoptosis by estra-
diol was found to be independent of its 
eff ect on TGF-  . In isolated podocytes 
derived from the wild-type C57B / 6 mouse, 
testosterone had no eff ect on TGF-  levels. 
In addition, in this model, estradiol 
induced extracellular signal-regulated 
kinase 1 (ERK1) and ERK2 activity, which 
was shown to be related to its antiapop-
totic eff ects. 
 Podocytes have been implicated in the 
development and progression of a variety 
of renal diseases, such as focal segmental 
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 Figure 1  |  Sex hormones and the kidney. CK2, casein kinase II; COL, collagen; E2, estradiol;  
ERK, extracellular signal-regulated kinase; MMP, matrix metalloproteinase; T, testosterone; TGF- β , 
transforming growth factor- β ; TIMP, tissue inhibitor of metalloproteinase. 
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glomerulosclerosis and diabetic nephro-
pathy. Th is study suggests that glomeru-
losclerosis in   ERKO mice is associated 
with podocyte damage, and that cultured 
podocytes derived from the related wild-
type mouse become apoptotic under 
the influence of testosterone and are 
protected from this testosterone eff ect 
by estradiol. 
 Th e study by Doublier and co-workers 9 
adds to our understanding of the direct 
eff ects of sex hormones on the kidney and 
helps clarify the etiology of glomerulo-
sclerosis in the   ERKO mouse. The 
authors have identified an association 
between sex hormone-driven glomerulo-
sclerosis and podocyte damage in this 
model  in vivo , identifi ed the presence of 
ER  , ER  , and androgen receptors in cul-
tured podocytes from wild-type mice, and 
elucidated the interplay between estradiol 
and testosterone in the development of 
apoptosis in these cultured podocytes. 
 Clearly, sex hormones interact with 
pathways that result in kidney scarring 
and damage. The specific interplay 
between ER  and ER  , which is particu-
larly germane, remains to be elucidated. 
Further studies exploring these issues are 
warranted. 
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